| 1. |
2023
Tung-Wei Hsu,Hsin-An Chen,Wan-Yu Wang,Yen-Hao Su,Ming-Te Huang,Po-Hsiang Liao.
Chaperone-mediated autophagy degrade Dicer to promote breast cancer metastasis
. Journal of Cellular Physiology
.2023
;(238):829-841
|
|
| 2. |
2022
Chia-Hung Hsu,Hon-Ping Ma,Jiann Ruey Ong,Ming-Shou Hsieh.
Cancer-associated exosomal CBFB facilitate the aggressive phenotype, evasion of oxidative stress, and preferential predisposition to bone prometastatic factor of breast cancer progression
. Disease Markers
.2022
;(2022)
|
|
| 3. |
2022
Tung-Wei Hsu,Hsin-An Chen,Po-Hsiang Liao,Yen-Hao Su,Ching-Feng Chiu,Shian-Ying Sung.
Dicer-mediated miR-200b expression contributes to cell migratory/ invasive abilities and cancer stem cells properties of breast cancer cells
. Aging
.2022
;(14)
|
|
| 4. |
2022
Ruo-Kai Lin, Shih-Yun Lin,,Thi Anh Thu Le,Phui-Ly Liew,Cheng-Yang Lee,Chin-Sheng Hung.
Hypermethylation of TMEM240 Predicts Poor Hormone Therapy Response and Disease Progression in Breast Cancer
. Molecular Medicine
.2022
|
|
| 5. |
2022
Shi Qian Lin,Hsueh Chi Wu,Yun Yun Chou,Yu Chun Yen,Ka Wai Tam.
Effect of patient decision aids on decisional conflict and regret associated with breast cancer surgery: a randomized controlled trial
. Breast Cancer
.2022
;(29):880-888
|
|
| 6. |
2021
Satriyo PB,Yeh CT.
4-Acetylantroquinonol B induced DNA damage response signaling and apoptosis via suppressing CDK2/CDK4 expression in triple negative breast cancer cells.
. Toxicology and Applied Pharmacology
.2021
;(422):115-493
|
|
| 7. |
2021
Su YH,Chen HA.
AXL is crucial for E1A-enhanced therapeutic efficiency of EGFR tyrosine kinase inhibitors through NFI in breast cancer.
. Environmental Toxicology
.2021
;(36):1278-1287
|
|
| 8. |
2021
Lin RK.
Automatic Detection of the Circulating Cell-Free Methylated DNA Pattern of GCM2, ITPRIPL1 and CCDC181 for Detection of Early Breast Cancer and Surgical Treatment Response.
. Cancers
.2021
;(13):1375-1380
|
|
| 9. |
2020
Su CM,Zhou JF,Chen HA.
Cryptanshinone Inhibits the Glycolysis and Inhibits Cell Migration Through PKM2/β-Catenin Axis in Breast Cancer
. Onco Targets and therapy
.2020
;(13):8629-8639
|
|
| 10. |
2020
Su YH,Chen HA,Su CM,Huang MT.
ERK-mediated transcriptional activation of Dicer is involved in gemcitabine resistance of pancreatic cancer
. Jornal of cellular physiology
.2020
|
|
| 11. |
2019
Tam KW.
Reply to correspondence concerning "Acupuncture on aromatase inhibitor-induced arthralgia in patients with breast cancer".
. Breast
.2019
;(45):119-120
|
|
| 12. |
2016
Chih-Ming Su,Ting-Yu Chang,Hui-Ping Hsu,Hui-Huang Lai,Jie-Ning Li,Yu-Jhen Lyu, Kuang-Tai Kuo, Ming-Te Huang, Jen-Liang Su, Pai-Sheng Chen.
A novel application of E1A in combination therapy with EGFR- TKI treatment in breast cancer
. Oncotarget
.2016
;(7):63924-63936
|
|
| 13. |
2016
Tam KW.
Recommendation for axillary lymph node dissection in women with early breast cancer and sentinel node metastasis: A systematic review and meta-analysis of randomized controlled trials using the GRADE system.
. Int J Sur
.2016
;(34):73-80
|
|
| 14. |
2015
Su CM.
miR-520h is crucial for DAPK2 regulation and breast cancer progression.
. Oncogene
.2015
;(35):1132-1142
|
|
| 15. |
2015
Su CM.
Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition
.
.2015
;(26):675-685
|
|
| 16. |
2014
Su CM.
Vascular endothelial growth factor-C upregulated contractin and promotes metastasis of esophageal squamous cell carcinoma.
. Annal od Surgical Oncology
.2014
;(supp):767-775
|
|
| 17. |
2014
Su CM.
Novel peptides suppress VEGFR-3 activity and antagonize VEGFR-3-mediated oncogenic effects
. Oncotarget
.2014
;(5):3825-3835
|
|